Greenpharma
Orléans, FR· latest recorded location
GREENPHARMA is named on 2 US grants and 10 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 2
- Published applications
- 10
- Inventors
- 19
- Granted in 2026 so far
- 0
- Most recent grant
- 10 Nov 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Technology areas
Share of 12 documents
Recent patents
- Dermocosmetic or pharmaceutical use of a composition comprising at least one inhibitor of some chemoattractant cytokines10 Nov 2020US 10,828,309 B2
- Use of silymarin and/or constituents thereof as skin or hair pigmentation promoters29 Oct 2013US 8,569,358 B2
- Geralexin and uses thereof for the treatment of retinal degenerative diseases13 Mar 2025US 2025/0084069 A1
- Inhibitors of ngal protein24 Feb 2022US 2022/0054493 A1
- Dermocosmetic or pharmaceutical use of a composition comprising at least one inhibitor of some chemoattractant cytokines19 Oct 2017US 2017/0296547 A1
- Cosmetics and pharmaceutical applications of gallic acid and gallic acid derivatives27 Apr 2017US 2017/0112737 A1
- Peptide-based compounds as new inhibitors of metalloectopeptidases, compositions comprising said compounds and their pharmaceutical and cosmetic uses11 Mar 2010US 2010/0062052 A1
Most cited
By later US patents